# ResMed Inc. (RMD)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $28.35B  
**Price:** $192.39 (-0.61%)

> ResMed Inc. is a healthcare company that develops and supplies digital health technologies and cloud-connected medical devices for respiratory care. Its core products support the treatment of sleep apnea, COPD, and other chronic diseases through flow generators, masks, and related accessories used in home-based and clinical settings. ResMed also provides software and data platforms that help clinicians, patients, and care providers monitor therapy and manage ongoing treatment more effectively. The company serves healthcare systems, medical professionals, and patients across multiple regions, with a strong presence in the Americas as well as Europe, Japan, and Australia. Headquartered in San Diego, California, ResMed plays an important role in the medical instruments and supplies market by combining device-based therapy with connected digital care solutions.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $5.15B | $3.05B | $1.69B | $1.40B | — |
| 2024 | $4.69B | $2.66B | $1.32B | $1.02B | — |
| 2023 | $4.22B | $2.36B | $1.13B | $898M | — |
| 2022 | $3.58B | $2.02B | $1.00B | $779M | — |
| 2021 | $3.20B | $1.84B | $904M | $475M | — |
| 2020 | $2.96B | $1.72B | $810M | $622M | — |
| 2019 | $2.61B | $1.49B | $579M | $405M | — |
| 2018 | $2.34B | $1.33B | $542M | $316M | — |
| 2017 | $2.07B | $1.20B | $426M | $342M | — |
| 2016 | $1.84B | $1.07B | $429M | $352M | — |
| 2015 | $1.68B | $1.01B | $409M | $353M | — |
| 2014 | $1.55B | $990M | $405M | $345M | — |
| 2013 | $1.51B | $941M | $355M | $307M | — |
| 2012 | $1.37B | $821M | $294M | $255M | — |
| 2011 | $1.24B | $741M | $267M | $227M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $8.17B | $2.21B | $5.97B | $1.21B | $658M |
| 2024 | $6.87B | $2.01B | $4.86B | $238M | $697M |
| 2023 | $6.75B | $2.62B | $4.13B | $228M | $1.43B |
| 2022 | $5.10B | $1.74B | $3.36B | $274M | $765M |
| 2021 | $4.73B | $1.84B | $2.89B | $295M | $643M |
| 2020 | $4.59B | $2.09B | $2.50B | $463M | $1.16B |
| 2019 | $4.11B | $2.04B | $2.07B | $147M | $1.26B |
| 2018 | $3.06B | $1.00B | $2.06B | $189M | $270M |
| 2017 | $3.47B | $1.51B | $1.96B | $822M | $1.08B |
| 2016 | $3.26B | $1.56B | $1.69B | $731M | $873M |
| 2015 | $2.18B | $594M | $1.59B | $717M | $301M |
| 2014 | $2.36B | $603M | $1.76B | $906M | $301M |
| 2013 | $2.21B | $600M | $1.61B | $876M | $301M |
| 2012 | $2.14B | $530M | $1.61B | $810M | $251M |
| 2011 | $2.07B | $338M | $1.73B | $735M | $100M |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $1.75B | $90M | $1.66B |
| 2024 | $1.40B | $99M | $1.30B |
| 2023 | $693M | $120M | $574M |
| 2022 | $351M | $135M | $216M |
| 2021 | $737M | $103M | $634M |
| 2020 | $802M | $95M | $707M |
| 2019 | $459M | $69M | $390M |
| 2018 | $505M | $63M | $442M |
| 2017 | $414M | $62M | $352M |
| 2016 | $548M | $59M | $489M |
| 2013 | $403M | $64M | $339M |
| 2012 | $383M | $47M | $336M |
| 2011 | $283M | $67M | $217M |
| 2010 | $188M | $57M | $131M |
| 2009 | $239M | $110M | $129M |

Source: [CompaniesByCap](https://companiesbycap.com/company/RMD)